Connect with us

Finance

CVS Health Appoints Former UPS And Pepsi Exec As Finance Chief, Stock Soars

Published

on

CVS Health Appoints Former UPS And Pepsi Exec As Finance Chief, Stock Soars

CVS Health Inc (NYSE:CVS) on Tuesday named Brian Newman as executive vice president and chief financial officer designate, effective April 21.

He will succeed current chief financial officer Tom Cowhey, who will transition as a strategic advisor to president and chief executive officer David Joyner, effective May 12.

Newman was most recently executive vice president and chief financial officer of United Parcel Service Inc (NYSE:UPS).

Also Read: FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth’s PBMs Amid Commissioner Shortage

Before joining UPS, Newman spent 26 years with PepsiCo, where he held finance leadership roles across Europe, Asia, and North and South America. He also served as executive vice president for PepsiCo’s global operations and chief strategy officer. Newman began his career as an investment banker at PaineWebber.

Advertisement

Amy Compton-Phillips, the company’s new executive vice president and chief medical officer, effective May 19, will also report to David Joyner.

Dr. Compton-Phillips was most recently chief physician executive of Press Ganey, a health care performance improvement company.

Prior to Press Ganey, Dr. Compton-Phillips was the president and chief clinical officer at Providence Health & Services, a health care system, responsible for clinical operations and care including improving health, care, and value outcomes delivered by the system’s hospitals, clinics, and caregivers. From 1985 to 2007, she held positions of increasing responsibility at Kaiser Permanente.

In February, CVS Health reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.

Total revenues increased 4.2%, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, partially offset by a decline in the Health Services segment.

Advertisement

The Medical benefit ratio increased from 88.5% to 94.8% compared to the prior year, driven by increased utilization, the unfavorable impact of the previously disclosed decline in the company’s Medicare Advantage star ratings for the 2024 payment year, and the impact of higher acuity in Medicaid.

In October 2024, CVS Health appointed longtime executive David Joyner as its new president and CEO, replacing Karen Lynch amid the company’s ongoing financial struggles.

In November 2024, CVS Health appointed Prem Shah as the Group President, responsible for the operational performance across CVS Caremark, CVS Pharmacy, and the company’s Healthcare Delivery businesses.

In addition, the company appointed Steve Nelson as President of Aetna.

Advertisement

Price Action: At the last check on Tuesday, CVS stock was up 9.52% at $69.93 during the premarket session.

Read Next:

Photo via Shutterstock

UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.

Get the latest stock analysis from Benzinga?

Advertisement

This article CVS Health Appoints Former UPS And Pepsi Exec As Finance Chief, Stock Soars originally appeared on Benzinga.com

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Finance

Tech trade needs 2 things to remain 'in favor' this year

Published

on

Tech trade needs 2 things to remain 'in favor' this year
MJP Wealth Advisors chief investment officer Brian Vendig sits down with Morning Brief host Julie Hyman to discuss the tech trade’s (XLK) outlook for 2026. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
Continue Reading

Finance

Promising UK Penny Stocks To Watch In January 2026

Published

on

Promising UK Penny Stocks To Watch In January 2026
The UK market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. Despite these broader market pressures, investors may find intriguing opportunities in penny stocks—smaller or newer companies that can offer a mix of affordability and growth potential. While the term ‘penny stocks’ might seem outdated, their potential remains significant for those seeking financial strength and…
Continue Reading

Finance

Why Chime Financial Stock Was Music to Investor Ears in December | The Motley Fool

Published

on

Why Chime Financial Stock Was Music to Investor Ears in December | The Motley Fool

The company appears to be effectively serving its often-overlooked customer base.

The holiday month brought fintech Chime Financial (CHYM 3.13%) one of the best gifts a stock can receive — a substantial bump higher in price. Across December, Chime’s shares rose by more than 19%, lifted by a set of factors that included a recommendation upgrade from a prominent bank and a positive research note by an analyst who’s now tracking the company.

Good as gold

The bullish tone was set by that upgrade, which was made before market open on Dec. 1 by Goldman Sachs pundit Will Nance. According to his new evaluation, Chime stock is now a buy, up from Nance’s previous tag of neutral. The new price target is $27 per share.

Image source: Getty Images.

According to reports, the analyst’s move is based on the company’s new Chime Card, an innovative credit product that represents an evolution of the secured credit card (i.e., plastic that must be backed by a user’s actual funds).

Advertisement

In Nance’s estimation, as a next-generation credit product, the Chime Card should earn more “take” (i.e., fees derived from use) and thus higher revenue and profitability for the company than many anticipate. The prognosticator wrote that “attach” rates — i.e., Chime customer uptake — could also be notably above current expectations.

On Dec. 11, a new Chime bull emerged. This is B. Riley analyst Hal Goetsch, who initiated coverage of the company’s stock with a buy recommendation. This was accompanied by a price target of $35 per share, which is well higher than even Nance’s very optimistic assessment.

Goetsch waxed bullish about Chime’s high growth potential, according to reports. He opined that the company is doing well servicing its target segment of customers traditionally shunned by established banks due to poor credit histories, among other perceived flaws. It has also cleverly partnered with lenders and other financial services providers to offer attractive products such as the Chime Card.

Chime Financial Stock Quote

Today’s Change

(-3.13%) $-0.87

Current Price

Advertisement

$26.95

Executive shifts

Finally, Chime promoted no less than three of its executives to new positions. It announced in the middle of the month that former chief operating officer Mark Troughton had been named president, and Janelle Sallenave replaced him as chief operating officer (from chief experience officer). Vineet Mehra, meanwhile, became chief growth officer; previously, he was chief marketing officer.

All three appointments, announced in the middle of the month, were effective immediately.

Advertisement

As the year came to a close, it was apparent that the company had executives who were eager to keep contributing to its success. That, combined with those bullish analyst notes and the somewhat under-the-radar success story that the Chime Card appears to be, makes this fintech’s stock well worth watching. This is one of the more innovative young businesses in the financial sector at present.

Continue Reading

Trending